Call to Schedule Free Consultation at Over 45 Centers Worldwide!

Stem Cell Therapy For Alzheimer’s Disease

Stem Cell Therapy For Alzheimer’s Disease

When we consider the most popular ailments that affect the elderly populace, Alzheimer’s disease is top on the list. In the United States today, about 5.8 million patients over the age of 65 battle Alzheimer’s disease. With patients over the age of 75, there’s an 80% chance of being affected by this disease. 

Alzheimer’s disease is a neural disorder that occurs when the brain shrinks or atrophies. The condition causes the cells in the brain to die, which can escalate with time.

When we consider the causes, the most common one is dementia. Dementia on its own can cause a decline in thinking abilities, affecting both behavioral and social skills, which have an effect on the patient’s ability to function properly and independently.

Alzheimer’s disease is a progressive brain disorder that slowly destroys memory and cognitive skills. In the early stages of the disease, people may experience mild memory loss or confusion.

As the disease progresses, they may begin to lose their ability to communicate, take care of themselves, and recognize loved ones.

There is no one symptom of Alzheimer’s disease, and symptoms will differ from person to person. Below are some common early- and late-stage symptoms:

Early-stage symptoms:

Late-stage symptoms:

SEARCH

NEWSLETTER

CONTACT US FOR THERAPY

If you notice any of these symptoms in yourself or a loved one, it’s important to see a doctor right away. While there is no one test that can definitively diagnose Alzheimer’s disease, a combination of medical and cognitive tests can be used to rule out other potential causes of dementia.

Early diagnosis is important because it allows patients and their families to plan for the future and access treatments that can help slow the progression of the disease.

TREATMENT OF ALZHEIMER’S DISEASE

Before now, the available treatment options for Alzheimer’s disease have been temporary ones, and they were only used to manage the associated symptoms. However, with the introduction of stem cell therapy, there are now prospects for better and advanced treatment.

Stem Cells are typically multipotent cells that have the ability to differentiate into any cell type as required. Neurological diseases like Alzheimer’s disease have a high chance of causing incapacitation in patients, which may prevent the appropriate functioning of several parts of the brain.

At R3 Stem Cell, we offer such patients a chance to get a distinctive and effective treatment plan that can repair their brain damage. Human neural stem cell-derived extracellular vesicles deliver a higher chance than any existing treatment option to repair the brain damage associated with Alzheimer’s disease.

Brand Ambassador Gallery

The USA stem cell leader offers procedures in

7 Countries including:

SUCCESS STORIES

*Outcomes will vary between individuals. No claims are being made with regenerative therapies. The FDA considers stem cell therapy experimental. See our THERAPY COMMITMENT HERE.
service_icon1

R3 STEM CELL MASTER CLASS

Learn everything you need to know about the ever expanding field of regenerative medicine in this 8 part series that includes over four hours of entertaining content!

service_icon2

R3 STEM CELL INTERNATIONAL

R3 Stem Cell International includes 45 clinics in 7 countries. These Centers of Excellence treat all types of conditions with safe, effective protocols by expert stem cell physicians.

service_icon3

FREE STEM CELL CONSULTATION

R3 Stem Cell offers a no cost consultation to see if you or a loved one is a candidate for regenerative cell therapies including cytokines, growth factors, exosomes, and stem cells.

service_icon4

PROVIDER PARTNERSHIP

The R3 Partnership Program offers providers an all-in-one regenerative practice program including marketing, consultations and booked procedures!

FREE WEBINAR: AVOID SURGERY WITH STEM CELL THERAPY

The USA stem cell leader offers procedures in

7 Countries including:

No Comments

Sorry, the comment form is closed at this time.